Literature DB >> 23428169

Borderline personality disorder, bipolar disorder, depression, attention deficit/hyperactivity disorder, and narcissistic personality disorder: Practical differential diagnosis.

Otto F Kernberg1, Frank E Yeomans.   

Abstract

The challenge of accurate diagnosis remains at the heart of good psychiatric treatment. In the current state of psychiatry, a confluence of forces has increased this challenge for the clinician. These include practical pressures-such as limited time for diagnostic evaluation, the question of what is reimbursed by insurance, and the issue of directing patients to acute treatments-and also trends in nosology, such as the descriptive focus on signs and symptoms in the current official diagnostic system. The authors offer observations that we hope will help clinicians who have to make difficult diagnostic differentiations often under pressured circumstances. The paper is motivated both by the high frequency of diagnostic errors observed under such conditions and also by the belief that considering symptoms in the context of the patient's sense of self, quality of interpersonal relations, and level of functioning over time will help guide the diagnostic process.

Entities:  

Mesh:

Year:  2013        PMID: 23428169     DOI: 10.1521/bumc.2013.77.1.1

Source DB:  PubMed          Journal:  Bull Menninger Clin        ISSN: 0025-9284


  13 in total

Review 1.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

2.  Assessment of fluctuation between grandiose and vulnerable narcissism: Development and initial validation of the FLUX scales.

Authors:  Joshua R Oltmanns; Thomas A Widiger
Journal:  Psychol Assess       Date:  2018-06-21

Review 3.  [Bipolar disorders in DSM-5].

Authors:  E Severus; M Bauer
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

4.  Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  David Gloss; Jay K Varma; Tamara Pringsheim; Marc R Nuwer
Journal:  Neurology       Date:  2016-10-19       Impact factor: 9.910

Review 5.  Differential Diagnosis of Bipolar II Disorder and Borderline Personality Disorder.

Authors:  Adam Bayes; Gordon Parker; Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2019-11-20       Impact factor: 5.285

6.  Prosocial Behavior: Long-Term Trajectories and Psychosocial Outcomes.

Authors:  Elinor Flynn; Samuel E Ehrenreich; Kurt J Beron; Marion K Underwood
Journal:  Soc Dev       Date:  2015-08

7.  Predicting fluctuation in narcissistic states: An examination of the g-FLUX scale.

Authors:  Elizabeth A Edershile; Joshua R Oltmanns; Thomas A Widiger; Aidan G C Wright
Journal:  Psychol Assess       Date:  2020-10-22

8.  The impact of treatment decisions on the diagnosis of bipolar disorders.

Authors:  Emanuel Severus; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2014-03-18

Review 9.  Intersect between self-esteem and emotion regulation in narcissistic personality disorder - implications for alliance building and treatment.

Authors:  Elsa Ronningstam
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2017-02-07

10.  A clinical case study of a psychoanalytic psychotherapy monitored with functional neuroimaging.

Authors:  Anna Buchheim; Karin Labek; Steffen Walter; Roberto Viviani
Journal:  Front Hum Neurosci       Date:  2013-10-23       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.